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Outcomes of small for gestational age micropremies 
depending on how young or how small they are
Purpose: The outcomes of small for gestational age (SGA) infants 
especially in extremely low birth weight infants (ELBWIs) are 
controversial. This study evaluated the mortality and morbidity of 
ELBWIs, focusing on whether or not they were also SGA.
Methods: The medical records of 415 ELBWIs (birth weight <1,000 
g), who were inborn and admitted to the Samsung Medical Center 
neonatal intensive care unit from January 2000 to December 2008, 
were reviewed retrospectively. Mortality and morbidities were 
compared by body size groups: very SGA (VSGA), birth weight ≤3rd 
percentile; SGA, 3rd to 10th percentile; and appropriate for gestational 
age (AGA) infants, >10th percentile for gestational age. For gestational 
subgroup analysis, groups were divided into infants with gestational 
age ≤24
+6 weeks (subgroup I), 25
+0 to 26
+6 weeks (subgroup II), and 
≥27
+0 weeks (subgroup III).
Results: Gestational age was 29
+2±2
+6 weeks in the VSGA infants 
(n=49), 27
+5±2
+2 weeks in the SGA infants (n=45), and 25
+4±1
+4 weeks 
in AGA infants (n=321). Birth weight was 692±186.6 g, 768±132.9 g, 
and 780±142.5 g in the VSGA, SGA, and AGA groups, respectively. 
Cesarean section rate and maternal pregnancy-induced hypertension 
were more common in the VSGA and SGA than in AGA pregnancies. 
However, chorioamnionitis was more common in the AGA group. 
The mortalities of the lowest gestational group (subgroup I), and also of 
the lower gestational group (subgroup I+II) were signi  ficantly higher in 
the VSGA group than the SGA or AGA groups (P=0.020 and P=0.012, 
respectively). VSGA and SGA infants showed lower incidence in 
respiratory distress syndrome, ductal ligation, bronchopulmonary 
dysplasia, intraventricular hemorrhage than AGA group did. However, 
by multiple logistic regression analysis of each gestational subgroup, 
the differences were not significant.
Conclusion: Of ELBWIs, extremely SGA in the lower gestational 
subgroups, had an impact on mortality, which may provide information 
useful for prenatal counseling.
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Introduction
With social and environmental changes including increased 
maternal age and advances in in vitro fertilization techniques, the risk 
of preterm birth has increased. Of all preterm births, the proportion 
of extremely low birth weight infants (ELBWIs) has been rising; 
for example, the birth rate of ELBWIs in Korea increased by 360% 
from 1993 to 2007
1,2). However, with the development of improved 
prenatal and neonatal intensive care unit (NICU) care, including 
antenatal steroids, surfactant, meticulous mechanical ventilation, 
infection control, and early aggressive nutrition, both mortality 
and morbidity in ELBWIs has been reduced. With improved 
survival of ELBWIs, factors influencing mortality and morbidity in 
micropremies become an issue of current importance.
 In most preterm deliveries, small for gestational age (SGA) infants 
are generally associated with intrauterine growth restriction, which 
is caused by an inadequate supply of oxygen and nutrients that is 
attributable to placental insufficiency
3-5). It is generally thought that 
the frequency of mortality and morbidity in SGA infants is much 
higher than that in non-SGA infants. However, most studies have 
not properly adjusted for the confounding effect of gestational age, 
and therefore, the effect of SGA on prognosis, especially in ELBWIs, 
is uncertain.
 In this study, we evaluated the mortality and morbidity of 
ELBWIs focusing on whether or not the infants were SGA. We 
hypothesized that the prognosis for SGA ELBWIs would be different 
from appropriate for gestational age (AGA) ELBWIs, depending on 
the gestational subgroups and the severity of SGA.
Materials and methods
1. Subjects
This study was retrospective, involving 415 infants born with 
weight below 1,000 g and admitted to Samsung Medical Center 
NICU between January 2000 and December 2008. Among these 
infants, we excluded 1 infant with a gestational age of 21 weeks who 
died soon after birth. There were no cases of congenital anomalies, 
such as chromosomal abnormality or congenital infection.
For gestational subgroup analysis, infants of gestational age ≤24
+6 
weeks formed subgroup I, infants between 25
+0 and 26
+6 weeks 
formed subgroup II, and infants of gestational age≥27
+0 weeks formed 
subgroup III. The number of infants in each subgroup was as good as 
equally distributed (subgroup I, n=126; subgroup II, n=151; subgroup 
III, n=138).
The parents consented to have their infants cared for in the NICU 
and enrolled in the study using retrospective chart review.
2. Methods
We reviewed maternal medical records for factors including 
multiple pregnancy, in vitro fertilization, maternal pregnancy-
induced hypertension (PIH), pathologic chorioamnionitis (CAM), 
use of antenatal steroid, and mode of delivery. Also, we reviewed 
infants’ medical records for gestational age, birth weight, sex, 
Apgar scores, mortality and morbidities such as respiratory distress 
syndrome (RDS), patent ductus arteriosus (PDA), ductal ligation, 
bronchopulmonary dysplasia (BPD), pulmonary hypertension, 
intraventricular hemorrhage (IVH), periventricular leukomalacia 
(PVL), necrotizing enterocolitis (NEC), duration of total parenteral 
nutrition, and admission duration.
Gestational age was calculated by last menstrual period, evaluated 
by early prenatal obstetric ultrasonography, and confirmed by 
modified Ballard Score examined within 12 hours after birth
6,7). SGA 
was defined as birth weight under the 10th percentile for gestational 
age
8). In this study, we defined very SGA (VSGA) as birth weight 
≤3rd percentile for gestational age, and SGA was defined by a birth 
weight in the 3rd to 10th percentile for gestational age, thus the SGA 
group excluded VSGA infants. AGA infants had a birth weight in the 
10th to 90th percentile for gestational age. 
Neonatal mortality was defined as death before discharge. RDS 
was defined as respiratory distress needing oxygen over 40% to 
maintain PaO2 over 50 mmHg with radiological findings of air-
bronchogram, decreased lung volume, and bilateral reticular in-
filtration. Because RDS can be assessed soon after birth, mortality 
cases were included in the count of RDS. 
PDA was clinically diagnosed by symptoms and signs and 
confirmed by echocardiography. PDA was treated by indometh
-
acin and/or surgical ligation. Surgery was done in cases of con-
traindications to indomethacin or failed indomethacin therapy. 
The definition and severity of BPD was investigated according to 
the criteria established by Jobe and Bancalari
9). Moderate to severe 
BPD cases were considered significant. IVH was assessed by brain 
sonography
10) and IVH ≥grade 3 cases were counted. PVL was 
evaluated by brain magnetic resonance imaging or sonography at 
post menstrual age 36 weeks or more. NEC was defined by modified 
Bell's criteria
11) and stage ≥IIa was considered significant. Only 
survivors were included in the count of morbidities other than RDS.
 
3. Statistics
All analyses were performed using SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA). Categorical variables were analyzed by χ
2 test 
for a parametric test and Fisher’s exact test for non-parametric test, 
and comparisons of continuous variables were conducted with one-
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for a non-parametric test. P value <0.05 was considered statistically 
significant. 
Multivariate logistic regression analyses were done to evaluate 
outcomes after adjusting for confounding factors. Factors significant 
in the univariate analysis were included in the initial model. The 
demographic variables of gestational age, maternal PIH, pathologic 
CAM, and mode of delivery were considered confounding factors. 
Each variable was assessed by each outcome. Interactions between 
variables were considered, and a stepwise selection was used for 
modeling. For the final models, goodness-of-fit test was done 
according to the Hosmer and Lemeshow method of multivariate 
analysis.
Results
1. Demographic characteristics
The average gestational age was 26
+2±2
+2 weeks (range, 23
+0 to 34
+4 
weeks) and birth weight was 768±149 g (range, 350 to 999 g) in 415 
ELBWIs. The number of VSGA, SGA, and AGA infants was 49 
(11.8%), 45 (10.8%), and 321 (77.3%), respectively. 
The proportion of VSGA or SGA infants did not significantly 
increase during the time period; however, the ratio of infants with 
lower gestational age did increase (P=0.026).
There were 126 patients in subgroup I (≤24
+6 weeks), which was 
composed of 4 (3.2%) VSGA, 7 (5.6%) SGA, and 115 (91.3%) 
AGA infants. There were 151 patients in subgroup II (25
+0 to 26
+6 
weeks) with 8 (5.3%) VSGA, 3 (2.0%) SGA, and 140 (92.7%) AGA 
infants. There were 138 patients in subgroup III (≥27
+0 weeks) with 37 
(26.8%) VSGA, 36 (26.1%) SGA, and 65 (47.1%) AGA infants. 
Table 1 shows the demographic findings according to each 
body size group. Gestational age, birth weight, sex, maternal PIH, 
pathologic CAM, and delivery mode were significantly different 
between the VSGA, SGA, and AGA groups. Based on the result of 
the subgroup I and II analysis, there was no significant difference 
in gestational age that depended on body size. Subgroup III only 
showed significant difference in gestational age, depending on each 
body size group. Decreased male ratio in the SGA group was only 
significant in subgroup II (P=0.023). Maternal PIH and pathologic 
CAM were significantly different according to body size groups, even 
after being analyzed in gestational subgroups. The cesarean section 
rate was significantly increased only in subgroup III (P=0.009). 
The etiologies of being small were investigated, and PIH was 
identified as a dominant factor in both the SGA (25/45, 55.6%) 
and VSGA (30/49, 61.2%) groups. In the SGA group, discordant 
twin, gestational diabetes in the mother, and advanced maternal 
age contributed to 22.2% (10/45). Other risk factors for being small 
included donors of twin-to-twin transfusion cases, 6.7% (3/45) and 
preterm labor with oligohydramnios (because of membrane rupture), 
15.6% (7/45). In the VSGA group, factors leading to being small were 
discordant twin, placental anomaly, cord blood flow abnormality, 
maternal vascular disease, 26.5% (13/49), oligohydramnios with or 
without membrane rupture, 10% (5/49), and donor of twin to twin 
transfusion case, 2% (1/49).
2. Mortality rates
 The total mortality rate in ELBWIs was 24.1% (100/415). The 
mortality rate in each of the VSGA, SGA, and AGA groups is 
described in Table 2, showing no significant difference in mortality 
rates according to the body size. 
When analyzed by gestational subgroups, the mortality rate 
of subgroup I was 100% (4/4) in the VSGA group, resulting in 
a significant difference compared to AGA infants (P=0.020). In 
this lowest gestational age group, all the VSGA and SGA infant’ 
mortalities occurred within 28 days of birth. In contrast, 67% (32/48) 
of mortality cases in the AGA group occurred after 28 days of age. 
Table 1. Demographic Findings in Extremely Low Birth Weight Infants 
According to Body Size
VSGA
(n=49) 
SGA
(n=45)
AGA
(n=321) P value
Gestational age (wk) 29
+2±2
+6*† 27
+5±2
+2‡ 25
+4±1
+4 0.000
Subgroup I (≤24
+6 wk) 24
+2±0
+4 23
+2±0
+5 23
+6±0
+5 0.056
Subgroup II (25
+0-26
+6 wk) 25
+6±0
+5 25
+6±1
+0 25
+6±0
+4 0.990
Subgroup III (≥27
+0 wk)    30
+4±1+
6*† 28
+5±1
+0‡ 27
+5±0
+6 0.000
Birth weight (g) 692±187*
† 768±133 780±143 0.001
Subgroup I 404±41*
† 554±97 642±98 0.000
Subgroup II 479±39*
† 787±81 833±101 0.000
Subgroup III 769±144
 † 808±98
‡          908±71 0.000
Male      18 (36.7) 12 (26.7)
‡ 155 (48.3) 0.022
IVF      10 (20.4)  6 (13.3) 80 (24.9)   0.226
Multiple pregnancy 15 (30.6) 14 (31.1) 105 (32.8) 0.826
Antenatal steroid use      34 (69.4) 33 (73.3) 245 (76.3)   0.552
Maternal PIH     28 (57.1)
† 21 (46.7)
‡ 33 (10.3) 0.000
Pathologic CAM    4 (8.2)
†  7 (15.9)
‡ 150 (47.0)     0.000
Cesarean section    48 (98.0)*
† 38 (84.4) 245 (76.3) 0.001
Subgroup I 4 (100) 4 (57.1)   87 (75.7)   0.277
Subgroup II 8 (100) 1 (50.0) 108 (76.6) 0.196
Subgroup II 36 (97.3)
† 33 (91.7) 50 (76.9) 0.009
Values are presented as mean±SD or number (%).
VSGA, very small for gestational age (birth weight ≤3rd percentile for 
gestational age); SGA, small for gestational age (birth weight between 3rd 
to 10th percentile for gestational age); AGA, appropriate for gestational 
age (birth weight 10th to 90th percentile for gestational age); IVF, in vitro 
fertilization, PIH, pregnancy-induced hypertension; CAM, chorioamnionitis.
*P<0.05 in VSGA group, compared to SGA group. 
†P<0.05 in VSGA group, 
compared to AGA group. 
‡P<0.05 in SGA group, compared to AGA group.Korean J Pediatr 2011;54(6):1- • DOI: 10.3345/kjp.2011.54.6.246    249
The mortality in subgroup I VSGA infants was related to severe 
asphyxia in 3 cases, demonstrated by significantly lower 1 minute 
and 5 minutes Apgar scores. One of the mortality cases in this group 
was a donor in twin-to-twin transfusion syndrome, with intractable 
seizures because of massive brain hemorrhage soon after birth. 
Causes of death among subgroup I SGA infants included air leak, 
hemorrhagic shock, bowel perforation with shock, and septic shock 
with disseminated intravscular coagulopathy. The main causes of 
death in AGA infants were septic shock (18 cases) and cor pulmonale 
(13 cases) after 28 days of age.
The mortality in subgroup II was higher in the VSGA than in 
SGA or AGA group, however, there was no statistical significance. 
Subgroup II had only 3 mortality cases in the VSGA group. Causes 
of death were severe asphyxia, air leak, and bowel perforation with 
NEC, and all death were within 28 days of birth. The main causes of 
death in subgroup II AGA infants were not different from subgroup I.
Because the number of VSGA and SGA cases in subgroup II 
was small, the statistics of infants in subgroup I and II were assessed 
together. VSGA infants with gestational age <27 weeks (subgroup 
I+II) showed significantly increased mortality compared to AGA 
infants with gestational age <27 weeks (P=0.012). 
The mortality rate in subgroup III was not different in the VSGA, 
SGA, and AGA groups after adjusting a confounding factor, 
gestational ages.
3. Morbidities 
The VSGA group showed a significantly lower incidence of 
RDS, symptomatic PDA, ductal ligation, BPD (≥moderate), and 
IVH (≥grade 3) than the non-SGA group. However, by gestational 
subgroup analysis, the difference was not significant especially in 
subgroup I and II. In subgroup III, VSGA infants had lower RDS 
frequency than SGA or AGA infants (P<0.05) by univariate analysis. 
However, the RDS frequency in subgroup III VSGA infants was offset 
after adjusting confounding factors using multiple logistic regression 
analysis. Morbidities other than RDS in subgroup III were also 
Table 2. Mortalities in Extremely Low Birth Weight Infants According to 
Gestational Subgroups and Body Size
VSGA
(n=49) 
SGA
(n=45)
AGA
(n=321)
P 
value
Overall mortality 13/49 (26.5) 10/45 (22.2)         77/321 (24.0) 0.884
Subgroup I (≤24
+6 wk) 4/4 (100)
†       4/7 (57.1)           48/115 (41.7) 0.020
Subgroup II (25
+0-26
+6 wk)        3/8 (37.5) 0/3 (0.0) 22/140 (15.6) 0.220
Subgroup I+II (≤26
+6 wk)                    7/12 (58.3)
† 4/10 (40.0)           70/255 (27.5) 0.012
Subgroup III (≥27
+0 wk) 6/37 (16.2) 6/36 (16.7) 7/65 (10.8) 0.695
‡
1 min Apgar score 4.1±2.0 3.8±1.8 3.9±1.7 0.738
Subgroup I 1.3±0.5
†  2.7±1.3 3.4±1.5 0.012
Subgroup II 3.5±2.0 3.5±2.1 4.0±1.78 0.679
Subgroup III 4.5±1.9 4.1±1.8 4.7±1.7 0.233
5 min Apgar score 6.7±1.9 6.8±1.2 6.6±1.6  0.658
Subgroup I 2.8±2.2*
† 5.6±1.0 6.3±1.7 0.000
Subgroup II 5.9±2.2  8.0±0.0  6.7±1.7 0.259
Subgroup III 7.4±1.0  7.0±1.1 7.3±1.1  0.351
Values are presented as number (%) or mean±SD.
VSGA, very small for gestational age (birth weight ≤3rd percentile for 
gestational age); SGA, small for gestational age (birth weight between 3rd 
to 10th percentile for gestational age); AGA, appropriate for gestational age 
(birth weight 10th to 90th percentile for gestational age).
*P<0.05 in VSGA group, compared to SGA group. 
†P<0.05 in VSGA group, 
compared to AGA group. 
‡Adjusted for gestational age in subgroup III.
Table 3. Morbidities in Extremely Low Birth Weight Infants According 
to the Body Size
VSGA
(n=49) 
SGA
(n=45)
AGA
 (n=321) P value
RDS  31 (63.3) 39 (86.7) 281 (87.5)   0.000/0.112*
Subgroup I (≤24
+6 wk) 4 (100.0) 7 (100.0)   110 (99.1)  0.951
Subgroup II (25
+0-26
+6 wk) 8 (100.0)  2 (100.0) 126 (90.6)  0.599
Subgroup III (≥27
+0 wk) 19 (51.4)  30 (83.3)   45 (70.3)  0.245*
PDA  24 (66.7)  28 (80.0) 213 (87.3)   0.001/0.385*
Subgroup I  NA  3 (100.0)    64 (95.5)  1.000
Subgroup II 4 (80.0)  2 (100.0)  106 (91.4)    0.693
Subgroup III 20 (64.5)   23 (76.7)   43 (74.1)  0.869*
Surgical ligation  5 (13.9)  8 (22.9)   97 (39.8)   0.006/0.744*
Subgroup I  NA  2 (66.7)   48 (71.6)  1.000
Subgroup II 1 (20.0)  1 (50.0)   40 (33.6)  0.728
Subgroup III 4 (12.9)  5 (16.7)   9 (15.5)  0.105*
BPD (≥moderate)  13 (36.1)  12 (34.3) 130 (53.3)  0.028/0.200*
Subgroup I  NA   2 (66.7)   56 (83.6)  1.000
Subgroup II 4 (80.0)   1 (50.0)   53 (44.5)  0.295
Subgroup III 9 (29.0)   9 (25.7)   21 (36.2)  0.183*
Pulmonary hypertension   5 (13.9)   5 (14.3)   46 (18.9)  0.736
IVH (≥ grade 3)    0 (0.0) 2 (5.7) 35 (14.3)   0.017/0.264*
Subgroup I  NA 2 (66.7)   21 (31.3)  0.269
Subgroup II 0 (0.0) 0 (0.0) 12 (10.1)  0.679
Subgroup III 0 (0.0) 0 (0.0) 2 (3.4) 1.000*
PVL  0 (0.0) 0 (0.0) 7 (20.3)   0.804
NEC (≥stage IIa)    5 (10.2)  3 (6.7) 28 (8.7)    0.906
TPN duration (day) 30.9±27.4  27.1±17.2 30.0±20.2  0.704
Admission duration (day) 93.0±48.5 85.3±47.1 98.7±28.7   0.074
Values are presented as number (%) or mean±SD.
VSGA, very small for gestational age (birth weight ≤3rd percentile for 
gestational age); SGA, small for gestational age (birth weight between 3rd 
to 10th percentile for gestational age); AGA, appropriate for gestational age 
(birth weight 10th to 90th percentile for gestational age); RDS, respiratory 
distress syndrome; PDA, patent ductus arteriosus; BPD, bronchopulmonary 
dysplasia; IVH, intraventricular hemorrhage; PVL, periventricular 
leukomalacia; NEC, necrotizing enterocolitis; TPN, total parenteral neutrition; 
NA, not applicable.
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evaluated after adjusting for gestational age, resulting in no statistically 
significant difference between the body size groups (Table 3). 
Discussion
This study examined the effect of small for gestational age on 
mortality and morbidity in ELBWIs. The prognosis of preterm SGA 
infants, especially ELBWIs, is controversial because there are few 
studies of preterm SGA infants, and most of the outcomes have been 
confounded by varying gestational age and different populations. 
This retrospective study covering nine years was done in a single 
center, which is one of the largest NICUs in Korea. The ratio of 
ELBW SGA infants and the outcomes according to gestational 
age were not significantly different during the period, although the 
proportion of infants with lower gestational age has increased.
ELBW SGA infants seem to have a similar pathogenesis of being 
small, which is distinct from term or near term SGA infants who 
may have other etiologies of growth restriction. ELBW SGA infants 
were more likely to be born from PIH mothers. The pathogeneses of 
being small, maternal vascular disease, cord blood flow abnormality, 
placental anomaly, smaller placenta of discordant twins are all 
similar to PIH because they can cause ‘placental insufficiency’. In 
this study, the etiologies causing ‘placental insufficiency’ were present 
in 78% of SGA and 88% of VSGA groups. In contrast, ELBW 
AGA infants were more likely to be born from mothers with CAM 
mainly after preterm premature rupture of membranes. Thus, 
SGA and AGA preterm infants may experience different in utero 
environments. Different intrauterine fetal exposures can influence 
mortality and morbiditiy in ELBWIs. Infants exposed to placental 
insufficiency may have experienced chronic hypoxia and nutritional 
problems in utero
12), while, infants exposed to CAM with or without 
oligohydramnios may have experienced congenital infections 
and conditions unfavorable for lung development. Which of the 
two conditions is more influential in determining the outcome is 
uncertain. In this study, PIH or CAM alone was not a confounding 
factor for overall mortality or morbidity. 
In this study population, SGA infants were analyzed by SGA 
severity. The study showed that overall survival of VSGA, SGA, 
and AGA infants was similar. However, in subgroup I, the VSGA 
infants showed significantly higher mortality compared to AGA 
infants. Asphyxia was the main cause of death in the subgroup I 
VSGA infants, consistent with significantly lower Apgar scores in 
this group. It follows that the smaller the baby, the more their birth 
condition is an immediate extension of the in utero conditions. 
The mortality cases in the SGA and VSGA groups occurred in 
the early hours and days following birth, in contrast to those in 
the AGA group. Thrombocytopenia or neutropenia can occur in 
SGA infants as a result of chronic hypoxic stress in utero
12). Thus, 
VSGA or SGA infants are particularly vulnerable to bleeding 
with thrombocytopenia or infection associated with neutropenia 
especially early after birth. Initial complete blood count examinations 
showed that thrombocytopenia was present in 50% of subgroup I 
VSGA and SGA infants, compared to 9% of AGA infants (data not 
shown). Neutropenia was observed in 63% of subgroup I VSGA 
and SGA infants, compared to 13% of AGA infants (data not 
shown). Although there was no statistical significance, a high rate of 
thrombocytopenia or neutropenia may place VSGA and SGA groups 
at increased risk just after birth. 
The most serious morbidities that led to mortality were pulmonary 
hypertension (r
2=0.606, P=0.000) and NEC (r
2=0.511, P=0.000) 
in the study population. However, SGA status was not related to 
pulmonary hypertension or NEC even after the subgroup analysis 
was adjusted for gestational age. Khemani et al.
13) reported that 
severe pulmonary hypertension is involved in a high proportion of 
SGA infants and SGA with pulmonary hypertension was associated 
with worse outcomes from a 9-year study. However, the relationship 
between pulmonary hypertension and SGA status is uncertain, 
and in an experimental study, chronic hypoxia in utero did not 
induce pulmonary hypertension or precocious muscularization of 
the precapillary unit directly
14). This implies that lung condition, 
including BPD severity, may have an impact on pulmonary 
hypertension independent of SGA status.
Our result regarding NEC are inconsistent with some studies
15,16), 
but Bardin et al.
17) and Regev et al.
18), in agreement with our findings, 
showed no significant difference in the rate of NEC in SGA and 
AGA infants born before 27 weeks. Intrauterine growth restriction 
which is related to SGA status, is known as a risk factor for NEC 
following intestinal ischemia due to placental insufficiency
19-21). In our 
study population, the incidence of NEC was 14% in subgroup I and 
8% in subgroup II which was relatively low. At this incidence, a larger 
study sample would be required to reliably determine the impact of 
SGA on NEC.
RDS was decreased in the subgroup III VSGA group. Other 
studies report that the incidence of RDS is decreased in SGA infants 
due to accelerated lung maturation related to the stressful intrauterine 
environment
22,23). On the contrary, other studies report that 
placental insufficiency do not accelerate lung maturation but worsens 
respiratory outcome because these infants are exposed to “oxidative 
stress,” resulting in lung damage rather than lung maturation
24). An 
analysis adjusted for gestational age revealed that the RDS rate in 
subgroup III was not significantly different according to body sizes.
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significantly different depending on body size, after adjusting for 
gestational age. The prevalence of BPD in SGA infants is important 
in terms of long-term neurological outcome. There are some data 
suggesting that there are higher BPD rates in preterm SGA infants 
with longer ventilator duration and hospital stay than in AGA 
infants, which implies poorer neurologic outcomes in preterm 
SGA infants
22,25). However, our data showed that SGA or VSGA 
infants did not have increased risks of BPD or a longer hospital stay. 
Considering that some infants in AGA group were deceased with cor 
pulmonale, the effect of being small on BPD can be decreased more.
The rate of symptomatic PDA and ductal ligation was not 
significantly different according to body size according to a multi-
variate analysis. The effect of being small on PDA is also controversial. 
Several studies have suggested that maternal PIH may reduce the risk 
of symptomatic PDA because mothers with PIH are likely to deliver 
before labor and thus, have a low possibility of prostaglandin exposure 
which is known to be important for ductal patency
26). PDA incidence 
is mainly influenced by gestational age and the development of 
RDS
27). A report suggested that intrauterine inflammation can 
influence ductal patency
28). Therefore, the rate of PDA in SGA 
infants may be confounded by gestational age, RDS, and CAM. In 
our study, we used multivariate analysis to exclude such variants was 
done, and SGA status did not significantly influence the rate of PDA 
and ductal ligation.
The incidence of IVH in SGA infants is also controversial. Some 
studies have reported that the incidence of IVH is decreased in SGA 
infants from PIH mothers, suggesting that pre-exposure to hypoxia 
may induce adaptive mechanisms, with fetal cerebral blood flow 
modulated by prostanoids in utero
29,30). Meanwhile, several reports 
have shown that intrauterine inflammation is associated with IVH 
in preterm infants, suggesting a higher chance of IVH in AGA 
infants with CAM
31,32). However, the Vermont Oxford Network 
study reported that there was a trend toward an association of SGA 
with increased risks of IVH
16). IVH incidence was not different 
between SGA and AGA infants in another population study
18). In 
this study, being small did not affect the rate of IVH, after adjusting 
for gestational age. 
This study has a few limitations due to some missing infants 
whose birth weight might be over 1,000 g while gestational age at 
birth could be in the range of subgroup III. Thus, no significant 
difference in mortality and morbidity according to body size in 
subgroup III is inconclusive. However, the mortality difference 
according to body size with a summation of subgroup I and II, can be 
a useful information in the perinatal medicine. Getting information 
of micropremies below 27 weeks of age at birth, is now available 
due to advanced neonatal intensive care medicine. The number 
of SGA infants below 27 weeks of gestation is usually not enough 
for the investigation, though. Thus, survived SGA infants of lower 
gestational age should be more investigated for the understanding of 
morbidity outcomes. 
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